SCHEMBL22260288

SCHEMBL22260288

CCC(C)(C)c1cccc(-n2c3ccccc3c3ccccc32)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.47
▸ ATM Q13315 2/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.47
▸ MAPK1 P28482 2/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ CASP3 P42574 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ SENP8 Q96LD8 1/20 0.40
▸ SENP7 Q9BQF6 1/20 0.40
▸ SENP6 Q9GZR1 1/20 0.40
▸ PDE4A P27815 1/20 0.37
▸ PDE4B Q07343 1/20 0.37
▸ PDE4C Q08493 1/20 0.37
▸ PDE4D Q08499 1/20 0.37
▸ MAPK8 P45983 1/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ HPGD P15428 2/20 0.37
▸ CYP1A2 P05177 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13232925 0.90 KDM4E (0.43) KDM4EATML3MBTL1MAPK1NPC1
SCHEMBL13232931 0.90 KDM4E (0.43) KDM4EATML3MBTL1MAPK1NPC1
SCHEMBL22292306 0.88 KDM4E (0.44) KDM4EATML3MBTL1MAPK1PDE4A
SCHEMBL13077287 0.87 KDM4E (0.46) KDM4EATML3MBTL1MAPK1NPC1
SCHEMBL8739895 0.86 KDM4E (0.40) KDM4EATML3MBTL1MAPK1NPC1
SCHEMBL8739894 0.86 KDM4E (0.40) KDM4EATML3MBTL1MAPK1NPC1
SCHEMBL10090531 0.86 KDM4E (0.40) KDM4EATML3MBTL1MAPK1NPC1
SCHEMBL25722814 0.85 ATM (0.53) KDM4EATML3MBTL1MAPK1NPC1
SCHEMBL25752315 0.85 KDM4E (0.53) KDM4EATML3MBTL1MAPK1NPC1
SCHEMBL25453956 0.84 KDM4E (0.45) KDM4EATML3MBTL1MAPK8ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200235315-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2020-07-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200235315-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME TRPA1, PIEZO1, SLCO4C1 KDM4E 2311/4885ATM 4084/4885L3MBTL1 299/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback